UBS raises Covid-19 loss estimate to $30bn-$60bn

UBS has increased its insured loss estimate for Covid-19 to a range of $30bn-$60bn, from its previous range of $20bn-$40bn, with BI and credit and surety claims the two main drivers of losses.

To unlock article:

Login